Ahmad Bogari, Mohammed Jomah, Naif Alshehri, Hamad F Alrabiah, Abdullah Binghaith, Khalid AlOsaimi, Lulu Aldhwaihy, Alaa Baghazal, Hassan Bogari
{"title":"面部整形手术中的 5-氟尿嘧啶应用:5-氟尿嘧啶在面部整形手术中的应用:适应症、临床效果和安全性--系统回顾和元分析。","authors":"Ahmad Bogari, Mohammed Jomah, Naif Alshehri, Hamad F Alrabiah, Abdullah Binghaith, Khalid AlOsaimi, Lulu Aldhwaihy, Alaa Baghazal, Hassan Bogari","doi":"10.1055/a-2541-2644","DOIUrl":null,"url":null,"abstract":"<p><p>5-Fluorouracil (5-FU) is an antimetabolite that inhibits fibroblast proliferation and collagen synthesis, making it valuable in facial plastic surgery for scar modulation and other conditions. This systematic review examines the indications, outcomes, and safety of 5-FU in facial plastic surgery. Due to methodological heterogeneity across studies, a narrative synthesis was performed. A comprehensive search of MEDLINE, Cochrane, SCOPUS, EMBASE, PubMed, and Web of Science identified 32 eligible studies (1,456 patients) from 4,772 screened articles. Indications included keloids, hypertrophic scars, contractures, periocular scars, granulomas from filler complications, nasal skin thickening, infections following thread lifts, resistant facial warts, and hypochromic lesions. Most studies reported reductions in scar size, erythema, and recurrence rates, with combination therapies enhancing outcomes. Adverse effects were mild and transient. However, variability in dosing, administration frequency, and follow-up underscores the need for standardized treatment guidelines and long-term studies.</p>","PeriodicalId":12195,"journal":{"name":"Facial Plastic Surgery","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"5-Fluorouracil in Facial Plastic Surgery: Indications, Efficacy, and Safety - A Systematic Review and Narrative Synthesis.\",\"authors\":\"Ahmad Bogari, Mohammed Jomah, Naif Alshehri, Hamad F Alrabiah, Abdullah Binghaith, Khalid AlOsaimi, Lulu Aldhwaihy, Alaa Baghazal, Hassan Bogari\",\"doi\":\"10.1055/a-2541-2644\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>5-Fluorouracil (5-FU) is an antimetabolite that inhibits fibroblast proliferation and collagen synthesis, making it valuable in facial plastic surgery for scar modulation and other conditions. This systematic review examines the indications, outcomes, and safety of 5-FU in facial plastic surgery. Due to methodological heterogeneity across studies, a narrative synthesis was performed. A comprehensive search of MEDLINE, Cochrane, SCOPUS, EMBASE, PubMed, and Web of Science identified 32 eligible studies (1,456 patients) from 4,772 screened articles. Indications included keloids, hypertrophic scars, contractures, periocular scars, granulomas from filler complications, nasal skin thickening, infections following thread lifts, resistant facial warts, and hypochromic lesions. Most studies reported reductions in scar size, erythema, and recurrence rates, with combination therapies enhancing outcomes. Adverse effects were mild and transient. However, variability in dosing, administration frequency, and follow-up underscores the need for standardized treatment guidelines and long-term studies.</p>\",\"PeriodicalId\":12195,\"journal\":{\"name\":\"Facial Plastic Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2025-03-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Facial Plastic Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2541-2644\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Facial Plastic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2541-2644","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
摘要
5-氟尿嘧啶(5-FU)是面部整形手术的辅助治疗剂,用于治疗增生性疤痕、瘢痕疙瘩、肉芽肿、挛缩和鼻皮肤增厚。它减少疤痕,增强美观,改善功能,具有良好的安全性。本系统综述评估了5-FU在面部美学中使用的证据。方法综合检索MEDLINE、Cochrane、SCOPUS、EMBASE、PubMed、Web of Science,确定5-FU在面部美学中的研究。结果在4772篇文章中,32项研究(1456例患者)符合标准。适应症包括瘢痕疙瘩、增生性疤痕和挛缩(18项研究);眼周疤痕(6);肉芽肿(4);鼻皮肤增厚(1);感染(1);抗性疣(1);大多数研究报告了疤痕尺寸和红斑的改善。联合治疗和创新的给药方法以最小的副作用提高了结果。结论研究结果支持5-FU是一种安全、微创的治疗方法,可达到美观和功能目标。然而,标准化的方案和长期的研究是必要的。
5-Fluorouracil in Facial Plastic Surgery: Indications, Efficacy, and Safety - A Systematic Review and Narrative Synthesis.
5-Fluorouracil (5-FU) is an antimetabolite that inhibits fibroblast proliferation and collagen synthesis, making it valuable in facial plastic surgery for scar modulation and other conditions. This systematic review examines the indications, outcomes, and safety of 5-FU in facial plastic surgery. Due to methodological heterogeneity across studies, a narrative synthesis was performed. A comprehensive search of MEDLINE, Cochrane, SCOPUS, EMBASE, PubMed, and Web of Science identified 32 eligible studies (1,456 patients) from 4,772 screened articles. Indications included keloids, hypertrophic scars, contractures, periocular scars, granulomas from filler complications, nasal skin thickening, infections following thread lifts, resistant facial warts, and hypochromic lesions. Most studies reported reductions in scar size, erythema, and recurrence rates, with combination therapies enhancing outcomes. Adverse effects were mild and transient. However, variability in dosing, administration frequency, and follow-up underscores the need for standardized treatment guidelines and long-term studies.
期刊介绍:
Facial Plastic Surgery is a journal that publishes topic-specific issues covering areas of aesthetic and reconstructive plastic surgery as it relates to the head, neck, and face. The journal''s scope includes issues devoted to scar revision, periorbital and mid-face rejuvenation, facial trauma, facial implants, rhinoplasty, neck reconstruction, cleft palate, face lifts, as well as various other emerging minimally invasive procedures.
Authors provide a global perspective on each topic, critically evaluate recent works in the field, and apply it to clinical practice.